GW Plastics, a leader in precision injection molding and contract manufacturing to the healthcare market, announced today at the MD&M West 2016 Exposition in Anaheim, CA the completion of a major expansion of their state-of-the-art Dongguan, China facilities in response to their rapidly growing medical device contract manufacturing business.
Through this expansion, GW Plastics has more than doubled the size of their plant, and their new 125,000 square foot facility will permit the company to streamline their tooling, molding, and medical device assembly operations while leaving significant room for future contract manufacturing growth. Now fully operational, the new facilities feature product development and in-house tool building services, scientific injection molding capabilities to ensure device standardization, and both automated and manual assembly services. The company plans to enhance their Asia manufacturing capabilities with Liquid Silicone Rubber (LSR) injection molding, as well as customer product development support with increased prototyping, bridge tooling, mold sampling, and short-run production.
At the same time, GW Plastics has also broken ground on an expansion of their Royalton, VT facilities. This 21,000 square foot expansion – scalable to 50,000 square feet — will accommodate additional growth of its Thermoplastic and LSR injection molding and medical device contract assembly business. Expected to be complete later this spring, the expansion will allow for an additional 30 injection molding machines, an enlarged Class 8 LSR cleanroom, and an expansion of its Scientific Molding Process Development and Training Center. This expansion will allow GW Plastics’ affiliate, GW Silicones, to add needed capacity to support ongoing growth. GW Silicones now offers internal LSR tool building capabilities, flash-less molding, automated assembly, and optical grade LSR molding.
With the expansions of its facilities in the US and China, GW Plastics provides their customers with the option to commercialize a project domestically in the United States or in a low-cost country (LCCS ), delivering a flexible, yet cost-effective manufacturing alternative that many companies cannot offer. “This has allowed us to become a natural extension of our customers’ production capabilities by providing them with a reliable and proven partner to confidently develop and manufacture their finished medical devices across the globe,” said Brenan Riehl, GW Plastics President and CEO.
Global market-leading companies trust GW Plastics to deliver their most challenging projects. To learn more about how their contract manufacturing capabilities can help you succeed with your next project, please visit their booth #1909 at the MD&M West 2016 Exposition in Anaheim, CA this February 9-11. For more information on their contract manufacturing capabilities, please contact Anthony Fleszar, GW Plastics North America Sales Manager, at Anthony.Fleszar@GWPlastics.com or visit their website at www.GWPlastics.com.
About GW Plastics